Mental health case conferences in primary care: Content and treatment decision making

Research in Social and Administrative Pharmacy

Volumn 3, Issue 1, 2007, Pages 86-103

  Bell, J Simon ^a,b   Aslani, Parisa ^b   McLachlan, Andrew J ^b   Whitehead, Paula ^c   Chen, Timothy F ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Case conferences; Community mental health; Decision making; Home Medicines Review; Pharmacy

Indexed keywords

ARTICLE; CASE MANAGEMENT; COOPERATION; DECISION MAKING; DRUG USE; GENERAL PRACTITIONER; GROUP PROCESS; HUMAN; MENTAL DISEASE; PATIENT CARE; PHARMACIST; PHARMACY; PRIMARY HEALTH CARE; PUBLIC RELATIONS;

CASE MANAGEMENT; COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; DECISION MAKING; DRUG UTILIZATION REVIEW; GROUP PROCESSES; HUMANS; INTERPROFESSIONAL RELATIONS; MENTAL DISORDERS; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE;

EID: 33847666411     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2006.05.005     Document Type: Article

References (50)

1. Grumbach K., and Bodenheimer T. Can health care teams improve primary care practice?. JAMA 291 (2004) 1246-1251
2. Gibbon B. An investigation of interprofessional collaboration in stroke rehabilitation team conferences. J Clin Nurs 8 (1999) 246-252
3. Colombo A., Bendelow G., Fulford B., and Williams S. Evaluating the influence of implicit models of mental disorder on processes of shared decision making within community-based multi-disciplinary teams. Soc Sci Med 56 (2003) 1557-1570
4. Hickie I.B. Can we reduce the burden of depression? The Australian experience with beyondblue: the national depression initiative. Australas Psychiatry 12 (2005) S38-S46
5. Herrman H., Trauer T., and Warnock J. The roles and relationships of psychiatrists and other service providers in mental health services. Aust N Z J Psychiatry 36 (2002) 75-80
6. Liberman R.P., Hilty D.M., Drake R.E., and Tsang H.W.H. Requirements for multidisciplinary teamwork in psychiatric rehabilitation. Psychiatr Serv 52 (2001) 1331-1342
7. Hughes C.M., and McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 53 (2003) 600-606
8. Davis R., and Thurecht R. Care planning and case conferencing: building effective multidisciplinary teams. Aust Fam Physician 30 (2001) 78-81
9. Royal S., Smeaton L., Avery A.J., Hurwitz B., and Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 15 (2006) 23-31
10. Bell S., McLachlan A.J., Aslani P., Whitehead P., and Chen T.F. Community pharmacy services to optimise the use of medications for mental illness: a systematic review. Aust New Zealand Health Policy 2 (2005) 29
11. Rickles N.M., Svarstad B.L., Statz-Paynter J.L., Taylor L.V., and Kobak K.A. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc 45 (2005) 344-353
12. Rickles N.M., Svarstad B.L., Statz-Paynter J.L., Taylor L.V., and Kobak K.A. Improving patient feedback about and outcomes with antidepressant treatment: a study in eight community pharmacies. J Am Pharm Assoc 46 (2006) 25-32
13. Finley P.R., Rens H.R., Pont J.T., et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm 59 (2002) 1518-1526
14. Finley P.R., Rens H.R., Pont J.T., et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 23 (2003) 1175-1185
15. National Strategy for the Quality Use of Medicines. Commonwealth of Australia. 2002.
16. Australian Medicines Handbook (2005), Australian Medicines Handbook Pty Ltd, Adelaide
17. Lambert T., Velakoulis D., and Pantelis C. Medical comorbidity in schizophrenia. Med J Aust 178 (2003) S67-S70
18. Jyrkka J., Vartiainen L., Hartikainen S.A., Sulkava R., and Enlund H. Increasing use of medicines in elderly persons: a five year follow-up of the Kuopio 75+ study. Eur J Clin Pharmacol 62 (2006) 151-158
19. Fialova D., Topinkova E., Finne-Soveri H., et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293 (2005) 1348-1358
20. Hartikainen S.A., Rahkonen T., Kautianen H., and Sulkava R. Use of psychotropics among home dwelling non-demented and demented elderly. Int J Geriatr Psychiatry 18 (2003) 1135-1141
21. Linjakumpu T.A., Hartikainen S.A., Klaukka T.J., et al. Sedative drug use in the home dwelling elderly. Ann Pharmacother 38 (2004) 2017-2022
22. Linjakumpu T.A., Hartikainen S.A., Klaukka T.J., Koponen H.J., Kivela S.-L., and Isoaho R.E. Psychotropics among the home dwelling elderly-increasing trends. Int J Geriatr Psychiatry 17 (2002) 874-883
23. Blakeman T., Harris M., Comino E., and Zwar N. Evaluating general practitioners' views about the implementation of the Enhanced Primary Care Medicare items. Med J Aust 175 (2001) 95-98
24. Foster P., and Foster J. Case conferencing: an effective means of managing ADHD. Aust Fam Physician 28 (1999) 647-648
25. Davies J.W., Ward W.K., Groom G.L., Wild A.J., and Wild S. The case conferencing project: a first step towards shared care between general practitioners and a mental health service. Aust N Z J Psychiatry 31 (1997) 751-755
26. Schmidt I., Claesson C.B., Westerholm B., Nilsson L.G., and Svarstad B.L. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 46 (1998) 77-82
27. Schmidt I.K., and Fastbom J. Quality of drug use in Swedish nursing homes-a follow up study. Clin Drug Invest 20 (2000) 433-446
28. Schmidt I.K., Claesson C.B., Westerholm B., and Nilsson L.G. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 32 (1998) 27-31
29. Pirkis J.E., Headey A.N., Burgess P.M., Whiteford H.A., White J.P., and Francis C. Remunerating private psychiatrists for participating in case conferences. Aust New Zealand Health Policy 2 (2005) 33
30. Harris M. Case conferences in general practice: time for a rethink?. Med J Aust 177 (2002) 93-94
31. Mitchell G., de Jong I., Del Mar C., Clavarino A., and Kennedy R. General practitioner attitudes to case conferences: how can we increase participation and effectiveness?. Med J Aust 177 (2002) 95-97
32. Mickan S., and Rodger S. Characteristics of effective teams: a literature review. Aust Health Rev 23 (2000) 201-208
33. Charles C., Gafni A., and Welan T. Decision making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49 (1999) 651-661
34. Charles C., Gafni A., and Whelan T. Shared decision making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 44 (1997) 681-692
35. Montori V.M., Gafni A., and Charles C. A shared treatment decision making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect 9 (2006) 25-36
36. Murray E., Charles C., Gafni A. Shared decision making in primary care: tailoring the Charles et al. model to fit the context of general practice. Patient Educ Couns. 2005. In press.
37. Maslen C.L., Rees L., and Redfern P.H. Role of the community pharmacist in the care of patients with chronic schizophrenia in the community. Int J Pharm Pract 4 (1996) 187-195
38. Badger E. The pharmacist's role in the medicinal management of depression. Nurs Stand 16 (2002) 33-40
39. Landers M., Blenkinsopp A., Pollock K., and Grime J. Community pharmacists and depression: the pharmacist as intermediary between patient and physician. Int J Pharm Pract 10 (2002) 253-265
40. Chen T.F., Crampton M., Krass I., and Benrimoj S.I. Collaboration between community pharmacists and GPs-impact on interprofessional communication. J Soc Adm Pharm 18 (2001) 83-90
41. Atwal A., and Caldwell K. Do all health and social care professionals interact equally: a study of interactions in multidisciplinary teams in the United Kingdom. Scand J Caring Sci 19 (2005) 268-273
42. Zillich A.J., McDonough R.P., Carter B.L., and Doucette W.R. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 38 (2004) 764-770
43. Doucette W.R., Nevins J., and McDonough R.P. Factors affecting collaborative care between pharmacists and physicians. Res Soc Adm Pharm 1 (2005) 565-578
44. Brock K.A., and Doucette W.R. Collaborative working relationships between pharmacists and physicians: an exploratory study. J Am Pharm Assoc 44 (2004) 358-365
45. Multidisciplinary case conferences. Australian Government Department of Health and Ageing 2006. Available at:. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-epc-caseconf.htm Accessed 21.02.06
46. Blakeman T., Harris M.F., Comino E., and Zwar N. Implementation of the enhanced primary care items requires ongoing education and evaluation. Aust Fam Physician 30 (2001) 75-77
47. Blakeman T.M., Zwar N.A., and Harris M.F. Evaluating general practitioners' views on the enhanced primary care items for care planning and case conferencing. Aust Fam Physician 31 (2002) 582-585
48. Vuokila-Oikkonen P., Janhonen S., and Vaisanen L. Shared-rhythm cooperation in cooperative team meetings in acute psychiatric inpatient care. J Psychiatr Ment Health Nurs 11 (2004) 129-140
49. Schmidt I.K., and Svarstad B.L. Nurse-physician communication and quality of drug use in Swedish nursing homes. Soc Sci Med (2002) 1767-1777
50. Carol G. Qualitative Research in Health (1998), Allen & Unwin, Sydney